Oura’s (OURA) initial public offering has attracted approximately four times the volume of orders compared to the shares available. Pricing is scheduled for Tuesday.
That level of interest has already driven pricing toward the upper bound of its targeted range. This strong investor rush follows a scarcity of billion-dollar public listings this year, prompting questions about what is truly fueling the demand.
The Order Book Says More About Supply Than Oura
A syndicate consisting of five banks, including Morgan Stanley and Goldman Sachs, is marketing 50 million shares. With pricing established between $40 and $44 per share, orders have exceeded that available supply by roughly four times.
At the upper limit of that pricing band, Oura’s market capitalization would attain $14.1 billion. Furthermore, Bloomberg calculates the fully diluted valuation at exceeding $15 billion.
That magnitude of demand appears less extraordinary when viewed against the sparse 2026 listing calendar. Kraken’s parent company delayed its public debut plans to 2027. Similarly, nuclear services provider Holtec Nuclear and insurance provider Bamboo Insurance Services postponed their public offerings, both pointing to unfavorable market conditions within days of one another.
Oura’s offering could represent the first to surpass $1 billion since Jersey Mike’s market debut in July. Consequently, market scarcity rather than absolute conviction may be driving much of the pricing.
In a separate development, former New York Federal Reserve Bank president Bill Dudley cautioned that the broader stock market is residing in bubble territory. This underlying environment flatters a select few clean, well-marketed transactions.
The Fundamentals Are Real, Just Not That Rare
Oura’s previous IPO filings demonstrated authentic business growth. Over a nine-month period, revenue advanced 74% to reach $1.21 billion, while paid subscribers doubled to five million.
Net income climbed to $60.8 million, up from a mere $1.6 million during the prior year. Nevertheless, Oura recorded a $924.3 million loss attributable to common shareholders, though that specific charge stemmed from a preferred-stock buyback rather than core operations.
Hardware sales continue to account for the majority of top-line revenue. Ring purchases generated $974 million, compared to just $240.5 million produced by subscriptions. This distribution resembles a traditional hardware manufacturer more than the software valuation multiple being applied to Oura.
A comparable narrative is reflected in Whoop’s recent $575 million funding round at a $10.1 billion valuation. Investors are pricing the entire wearable technology sector liberally, extending beyond Oura alone.
What Tuesday Actually Tests
Achieving a fourfold oversubscription merely indicates to underwriters the volume of orders they can distribute. It offers very little insight into how the equity will perform in secondary trading after it goes public.
Ultimately, members will determine whether the subscription cost of a ring is justified by the health data it gathers.